Immune responses and immunity in hepatitis C virus infection

Journal of Gastroenterology

Volumn 36, Issue 12, 2001, Pages 799-808

  Mizukoshi, E ^a   Rehermann, B ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

Author keywords

CTL; HCV; Helper T cell; Immune response; Innate

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE; DOUBLE STRANDED RNA; GAMMA INTERFERON; INTERLEUKIN 12; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; CHIMPANZEE; CLINICAL FEATURE; CONTROLLED STUDY; DENDRITIC CELL; GENE MUTATION; GRANULOCYTE; HEPATITIS C; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNE STATUS; IMMUNITY; MACROPHAGE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PERSISTENT INFECTION; PRIORITY JOURNAL; REVIEW; STEM CELL;

HEPACIVIRUS; HEPATITIS C; HUMANS; IMMUNITY; VACCINES;

EID: 0035673314     PISSN: 09441174     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005350170001     Document Type: Review

References (96)

1. The past incidence of hepatitis C virus infection: Implications for the future burden of chronic liver disease in the United States
2. Hepatitis C virus: Detection of intracellular virus particles by electron microscopy
3. Hepatitis C virus particle detected by immunoelectron microscopic study
4. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties
5. Molecular virology of the hepatitis C virus
6. Hepatitis C viruses
7. Direct triggering of the type I interferon system by virus infection: Activation of a transcription factor complex containing IRF-3 and CBP/p300
8. Noncytolytic control of viral infections by the innate and adaptive immune response
9. Efficient initiation of HCV RNA replication in cell culture
10. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway
11. The human liver contains multiple populations of NK cells, T cells, and CD3+CD56+ natural T cells with distinct cytotoxic activities and Th1, Th2, and Th0 cytokine secretion patterns
12. Activating Ly-49 NK receptors: Central role in cytokine and chemokine production
13. The nature of the principal type 1 interferon-producing cells in human blood
14. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon
15. Natural interferon alpha/beta-producing cells link innate and adaptive immunity
16. The instructive role of innate immunity in the acquired immune response
17. Innate immune induction of the adaptive immune response
18. The role of chemokine receptors in primary, effector, and memory immune responses
19. DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C virus infection
20. The chimpanzee model of hepatitis C virus infections
21. Dendritic cells are sufficient to cross-present self-antigens to CD8 T cells in vivo
22. Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection
23. Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: Enrichment for Valpha24+ T cells and rapid elimination of effector cells by apoptosis
24. Antigen-specific primary activation of CD8(+) T cells within the liver
25. Expression of C-C chemokines is associated with portal and periportal inflammation in the liver of patients with chronic hepatitis C
26. Perspective: Virus infections and the death of neurons
27. Patients infected with the same hepatitis C virus strain display different kinetics of the isolate-specific antibody response
28. Epitope mapping of antibodies directed against hypervariable region 1 in acute self-limiting and chronic infections due to hepatitis C virus
29. Early antibody response against hypervariable region 1 is associated with acute self-limiting infections of hepatitis C virus
30. Acute hepatitis C virus structural gene sequences as predictors of persistent viremia: Hypervariable region 1 as a decoy
31. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies
32. A quantitative test to estimate neutralizing antibodies to the hepatitis C virus: Cytofluorimetric assessment of envelope glycoprotein 2 binding to target cells
33. Binding of hepatitis C virus to CD81
34. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C
35. Vaccination of chimpanzees against infection by the hepatitis C virus
36. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization
37. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein
38. A hyperimmune serum against a synthetic peptide corresponding to the hypervariable region 1 of hepatitis C virus can prevent viral infection in cell cultures
39. Conservation of the conformation and positive charges of hepatitis C virus E2 envelope glycoprotein hypervariable region 1 points to a role in cell attachment
40. Viral persistence, antibody to E1 and E2, and hypervariable region 1 sequence stability in hepatitis C virus-inoculated chimpanzees
41. Long-term follow-up of chimpanzees inoculated with the first infectious clone for hepatitis C virus
42. Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response
43. Immunodominant CD4+ T-cell epitope within nonstructural protein 3 in acute hepatitis C virus infection
44. Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C
45. Activation of cytokine genes in T cells during primary and secondary murine influenza pneumonia
46. A case for cytokines as effector molecules in the resolution of virus infection
47. Interleukin 4 is important in protective immunity to a gastrointestinal nematode infection in mice
48. Fas-dependent CD4+ cytotoxic T-cell-mediated pathogenesis during virus infection
49. Detection of type 2-like T-helper cells in hepatitis C virus infection: Implications for hepatitis C virus chronicity
50. Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo
51. Alpha/beta-T cell receptor(TCR)+CD4-CD8-(NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10
52. CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site
53. Direct thymic involvement in anterior chamber-associated immune deviation: Evidence for a nondelectional mechanism of centrally induced tolerance to extrathymic antigens in adult mice
54. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease
55. Immunization with alphagalactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
56. Alpha-galactosylceramide induces early B-cell activation through IL-4 production by NKT cells
57. Cutting edge: Activation of NK T cells by CD1d and alpha-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
58. Intrahepatic cytotoxic T lymphocytes specific for hepatitis C virus in persons with chronic hepatitis
59. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV
60. HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release
61. Analysis of a successful immune response against hepatitis C virus
62. Analysis of successful immune responses in persons infected with hepatitis C virus
63. Association of hepatitis C virus-specific CD8+ T cells with viral clearance in acute hepatitis C
64. Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers
65. Nucleotide sequence and mutation rate of the H strain of hepatitis C virus
66. Genetic drift of hepatitis C virus during an 8.2-year infection in a chimpanzee: Variability and stability
67. The origin of hepatitis C virus genotypes
68. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor
69. T cell receptor antagonists and partial agonists
70. Altered peptide ligand-induced partial T cell activation: Molecular mechanisms and role in T cell biology
71. Understanding the mechanisms of sustained signaling and T cell activation
72. Natural variants of cytotoxic epitopes are T-cell receptor antagonists for antiviral cytotoxic T cells
73. Cytotoxic T-cell activity antagonized by naturally occurring HIV-1 Gag variants
74. Evolution and transmission of stable CTL escape mutations in HIV infection
75. Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus
76. Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity
77. Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope
78. Hypervariable region 1 variants act as TCR antagonists for hepatitis C virus-specific CD4+ T cells
79. Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein
80. Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway
81. Suppression of host immune response by the core protein of hepatitis C virus: Possible implications for hepatitis C virus persistence
82. Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation
83. Cellular immune responses persist, humoral responses decrease two decades after recovery from a single source outbreak of hepatitis C
84. T- and B-cell responses to different hepatitis C virus antigens in patients with chronic hepatitis C infection and in healthy anti-hepatitis C virus-positive blood donors without viremia
85. T-cell response to structural and nonstructural hepatitis C virus antigens in persistent and self-limited hepatitis C virus infections
86. Differential CD4 and CD8 T-cell responsiveness in hepatitis C virus infection
87. Antigen-independent activation of naive and memory resting T cells by a cytokine combination
88. Long lasting memory T cell responses following self-limited acute hepatitis B
89. Recurrent and new hepatitis C virus infection after liver transplantation
90. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained
91. Catabolism of homologous murine monoclonal hybridoma IgG antibodies in mice
92. The half-lives of serum immunoglobulins in adult mice
93. Protective T cell-independent antiviral antibody responses are dependent on complement
94. Maintenance of B-cell memory by long-lived cells generated from proliferating precursors
95. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection
96. Intrahepatic genetic inoculation of hepatitis C virus RNA confers cross-protective immunity